Pharmazz, Inc.
WILLOWBROOK, IL · Founded 2017 · CIK 0001729963 · Biotech · Private
Centhaquin citrate, a small-molecule adrenergic agent for treating hemorrhagic shock
pharmazz.com →- Grants
- $277K
- 1 award
- Sector median: 1
- Raised
- $25M
- 9 Form D · Jun 2025
- 16 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 1 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Toxicokinetics and toxicity of centhaquin in dogs | $277,059 | |
| Private capital raised | Form D · SEC | $299,299 | |
| Private capital raised | Form D · SEC | $2,196,000 | |
| Private capital raised | Form D · SEC | $1,405,500 | |
| Private capital raised | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $2,300,000 | |
| Private capital raised | Form D · SEC | $450,000 | |
| Private capital raised | Form D · SEC | $150,000 | |
| Private capital raised | Form D · SEC | $7,500,000 | |
| Private capital raised | Form D · SEC | $10,037,500 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2461 | Expesicor Inc | — | — |
| 2462 | Actym Therapeutics, Inc. | — | $25M |
| 2463 | Verseon Corp | — | $25M |
| 2464 | Pharmazz, Inc. | — | $25M |
| 2465 | Abzena plc | — | $4.3M |
| 2466 | CURADEL SURGICAL INNOVATIONS, INC. | — | $24M |
| 2467 | Vaxart, Inc. | — | $23M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- David CostelloExecutive Officer
- Anil GulatiDirector · Executive Officer
- Sunil GulatiExecutive Officer
- Jane KiernanDirector
- Dharminder MarwahDirector · Executive Officer
- James McConnellDirector
- James McDonnellDirector
- Guru ReddyExecutive Officer
- Ajit SrimalDirector · Executive Officer
- Daniel StauderExecutive Officer
- Gaylord ToftExecutive Officer
Patents
- Alterations in Endothelin Receptors Following Hemorrhage and Resuscitation by Centhaquingranted
- Lyophilized Sovateltide-based Injectable Formulation And A Process For Preparationapplication
- Lyophilized Sovateltide-based Injectable Formulation And Method For Preparation Thereofapplication
- Pharmaceutical Formulation For Treatment Of Cerebral Strokeapplication
- Pharmaceutical Composition And Method For Prevention And Treatment Of Hearing Lossapplication
- Composition And Method For Wound Healing And Repair Of Damaged Nervesapplication
- Methods And Compositions For Hypotensive Resuscitationapplication
- Pharmaceutical Composition And Method For Treatment Of Acute Respiratory Distress Syndrome (ards) In Coronavirus Disease (COVID-19)application
- Pharmaceutical Composition And Method For Treatment Of Coronavirus Disease (COVID-19)application
- Lyophilized Centhaquine Citrate Injection Formulation And A Method For The Sameapplication
- Composition And Method For Wound Healing And Repair Of Damaged Nervesapplication
- Alterations In Endothelin Receptors Following Hemorrhage And Resuscitation By Centhaquinapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.